337 related articles for article (PubMed ID: 36296329)
1. The Protective Effects of Nutraceutical Components in Methotrexate-Induced Toxicity Models-An Overview.
Marin GE; Neag MA; Burlacu CC; Buzoianu AD
Microorganisms; 2022 Oct; 10(10):. PubMed ID: 36296329
[TBL] [Abstract][Full Text] [Related]
2. Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota.
Huang X; Fang Q; Rao T; Zhou L; Zeng X; Tan Z; Chen L; Ouyang D
Toxicol Appl Pharmacol; 2020 Mar; 391():114900. PubMed ID: 32061593
[TBL] [Abstract][Full Text] [Related]
3.
Zhou B; Dong C; Zhao B; Lin K; Tian Y; Zhang R; Zhu L; Xu H; Yang L
Front Microbiol; 2022; 13():1015130. PubMed ID: 36590441
[TBL] [Abstract][Full Text] [Related]
4. Induction and Amelioration of Methotrexate-Induced Gastrointestinal Toxicity are Related to Immune Response and Gut Microbiota.
Zhou B; Xia X; Wang P; Chen S; Yu C; Huang R; Zhang R; Wang Y; Lu L; Yuan F; Tian Y; Fan Y; Zhang X; Shu Y; Zhang S; Bai D; Wu L; Xu H; Yang L
EBioMedicine; 2018 Jul; 33():122-133. PubMed ID: 30049384
[TBL] [Abstract][Full Text] [Related]
5. Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury.
Xia Y; Shi H; Qian C; Han H; Lu K; Tao R; Gu R; Zhao Y; Wei Z; Lu Y
Front Immunol; 2022; 13():874878. PubMed ID: 35634319
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation.
Nayak RR; Alexander M; Deshpande I; Stapleton-Gray K; Rimal B; Patterson AD; Ubeda C; Scher JU; Turnbaugh PJ
Cell Host Microbe; 2021 Mar; 29(3):362-377.e11. PubMed ID: 33440172
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
[TBL] [Abstract][Full Text] [Related]
8. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
[TBL] [Abstract][Full Text] [Related]
9. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
10. Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity.
Tang D; Zeng T; Wang Y; Cui H; Wu J; Zou B; Tao Z; Zhang L; Garside GB; Tao S
Gut Microbes; 2020 Nov; 12(1):1714401. PubMed ID: 31983316
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute lymphoblastic leukemia from traditional chinese medicine.
Hsiao YL; Chang PC; Huang HJ; Kuo CC; Chen CY
Evid Based Complement Alternat Med; 2014; 2014():601064. PubMed ID: 25136372
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity.
van Ede AE; Laan RF; Blom HJ; De Abreu RA; van de Putte LB
Semin Arthritis Rheum; 1998 Apr; 27(5):277-92. PubMed ID: 9572710
[TBL] [Abstract][Full Text] [Related]
13. Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis.
Qiu Q; Deng J; Deng H; Yao D; Yan Y; Ye S; Shang X; Deng Y; Han L; Zheng G; Roy B; Chen Y; Han L; Huang R; Fang X; Lu C
Front Immunol; 2022; 13():937539. PubMed ID: 36159864
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying methotrexate-induced pulmonary toxicity.
Kim YJ; Song M; Ryu JC
Expert Opin Drug Saf; 2009 Jul; 8(4):451-8. PubMed ID: 19538103
[TBL] [Abstract][Full Text] [Related]
15. Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia.
Xu M; Wu S; Wang Y; Zhao Y; Wang X; Wei C; Liu X; Hao F; Hu C
Front Pharmacol; 2022; 13():1003812. PubMed ID: 36532750
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials.
Longo-Sorbello GS; Bertino JR
Haematologica; 2001 Feb; 86(2):121-7. PubMed ID: 11224479
[TBL] [Abstract][Full Text] [Related]
18. Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia.
Mahmoud LB; Mdhaffar M; Frikha R; Ghozzi H; Hakim A; Sahnoun Z; Elloumi M; Zeghal K
Adv Clin Exp Med; 2018 Aug; 27(8):1061-1068. PubMed ID: 29911750
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis aggravates methotrexate toxicity by fueling RFC1-controlled intestinal absorption in rheumatic rats.
Wang QH; Pan S; Yang K; Wu YJ; Cheng XP; Olatunji OJ; Mao Q; Zuo J
Biomed Pharmacother; 2022 Jun; 150():113067. PubMed ID: 35658235
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition.
Warlick CA; Sweeney CL; McIvor RS
Biochem Pharmacol; 2000 Jan; 59(2):141-51. PubMed ID: 10810448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
